real-world study of tixagevimab/cilgavimab in pre-exposure prophylaxis for allosct recipients
Published 1 year ago • 110 plays • Length 2:25Download video MP4
Download video MP3
Similar videos
-
1:33
real-world multicenter study of caplacizumab in patients with acquired ttp
-
4:13
real-world study determining the safety and efficacy of teclistamab in r/r multiple myeloma
-
1:17
retrospective real-world study evaluating compassionate use of ponatinib in r/r ph-like all
-
0:45
difference between quality of life & patient-reported outcomes
-
0:52
insights from advance iv study: efgartigimod increases platelet counts of patients with itp
-
3:40
results of a study evaluating the predictive power of fish markers for pfs in al amyloidosis
-
1:19
the current state-of-the-art in pv and future outlooks
-
3:33
the growing role of machine learning in hematological oncology
-
1:02
maintenance therapy following treatment for amyloidosis
-
1:39
session highlights: the value of clinical hematology research groups
-
0:42
the importance of obtaining real-world data
-
1:27
the use of salvage second autologous transplant in the age of novel therapies for multiple myeloma
-
2:26
an insight into the aims of the eurasian hematology-oncology group
-
4:55
ebmt 2020: cellular therapy day
-
4:39
aml & mds: mac or ric?
-
8:11
current car-t climate in multiple myeloma
-
1:48
the oxplored study: t-cell type abundance and gene expression in early lymphoproliferative disorders